FOURTH AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 30th, 2024 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 30th, 2024 Company Industry JurisdictionThis Fourth Amended and Restated Employment Agreement (the “Agreement”) is made this 12th day of June, 2024 between Repligen Corporation, a Delaware corporation (the “Company”), and Anthony Hunt (the “Executive”) and shall become effective on September 1, 2024 (the “Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 30th, 2024 • Repligen Corp • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 30th, 2024 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made as of June 12, 2024 between Repligen Corporation, a Delaware corporation (the “Company”), and Olivier Loeillot (the “Executive”) and shall become effective on September 1, 2024 (the “Effective Date”). This Agreement amends, restates and supersedes in all respects the Employment Agreement between the Executive and the Company dated September 8, 2023 (the “Former Employment Agreement”), except that, to avoid doubt, the Executive’s confidentiality, noncompetition, nonsolicitation and other restrictive covenant obligations under the Former Employment Agreement are incorporated in this Agreement and remain unaltered and in effect.